• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食和肥胖对脂肪组织 ACE2 调节的概述。在 COVID-19 感染和严重程度方面的潜在影响。

An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and Severity.

机构信息

Nutrition and Obesity Group, Lucio Lascaray Research Center, Department of Nutrition and Food Science, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), 01006 Vitoria-Gasteiz, Spain.

CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain.

出版信息

Int J Mol Sci. 2021 Jul 26;22(15):7975. doi: 10.3390/ijms22157975.

DOI:10.3390/ijms22157975
PMID:34360741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8347022/
Abstract

The present review is aimed at analysing the current evidence concerning the potential modulation of obesity and/or diet in adipose tissue ACE2. Additionally, the potential implications of these effects on COVID-19 are also addressed. The results published show that diet and obesity are two factors that effectively influence the expression of gene in adipose tissue. However, the shifts in this gene do not always occur in the same direction, nor with the same intensity. Additionally, there is no consensus regarding the implications of increased adipose tissue ACE2 expression in health. Thus, while in some studies a protective role is attributed to ACE2 overexpression, other studies suggest otherwise. Similarly, there is much debate regarding the role played by ACE2 in COVID-19 in terms of degree of infection and disease outcomes. The greater risk of infection that may hypothetically derive from enhanced ACE2 expression is not clear since the functionality of the enzyme seems to be as important as the abundance. Thus, the greater abundance of ACE2 in adipose tissue of obese subjects may be counterbalanced by its lower activation. In addition, a protective role of ACE2 overexpression has also been suggested, associated with the increase in anti-inflammatory factors that it may produce.

摘要

本综述旨在分析目前关于肥胖和/或饮食对脂肪组织 ACE2 潜在调节的证据。此外,还探讨了这些影响对 COVID-19 的潜在意义。已发表的结果表明,饮食和肥胖是有效影响基因在脂肪组织中表达的两个因素。然而,这种基因的变化并不总是朝着相同的方向发生,也不是以相同的强度发生。此外,对于增加的脂肪组织 ACE2 表达对健康的影响,目前尚无共识。因此,虽然在一些研究中,ACE2 的过表达被认为具有保护作用,但其他研究则表明并非如此。同样,关于 ACE2 在 COVID-19 中感染程度和疾病结果方面的作用存在很多争议。从增强的 ACE2 表达可能带来的更高感染风险来看,尚不清楚,因为酶的功能与丰度同样重要。因此,肥胖患者脂肪组织中 ACE2 丰度的增加可能会被其较低的活性所抵消。此外,还提出了 ACE2 过表达的保护作用,它可能与 ACE2 产生的抗炎因子增加有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4cd/8347022/c06c5c3c5d02/ijms-22-07975-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4cd/8347022/18fcbb02d153/ijms-22-07975-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4cd/8347022/ad6723939a7f/ijms-22-07975-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4cd/8347022/2bf7e664ef91/ijms-22-07975-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4cd/8347022/c06c5c3c5d02/ijms-22-07975-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4cd/8347022/18fcbb02d153/ijms-22-07975-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4cd/8347022/ad6723939a7f/ijms-22-07975-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4cd/8347022/2bf7e664ef91/ijms-22-07975-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4cd/8347022/c06c5c3c5d02/ijms-22-07975-g004.jpg

相似文献

1
An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and Severity.饮食和肥胖对脂肪组织 ACE2 调节的概述。在 COVID-19 感染和严重程度方面的潜在影响。
Int J Mol Sci. 2021 Jul 26;22(15):7975. doi: 10.3390/ijms22157975.
2
Obesogenic and Ketogenic Diets Distinctly Regulate the SARS-CoV-2 Entry Proteins ACE2 and TMPRSS2 and the Renin-Angiotensin System in Rat Lung and Heart Tissues.肥胖相关和生酮饮食显著调节 SARS-CoV-2 进入蛋白 ACE2 和 TMPRSS2 以及大鼠肺和心脏组织中的肾素-血管紧张素系统。
Nutrients. 2021 Sep 25;13(10):3357. doi: 10.3390/nu13103357.
3
Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.SARS-CoV-2 受体 ACE2 在人心脏中的表达与不受控制的糖尿病、肥胖症以及肾素血管紧张素系统的激活有关。
Cardiovasc Diabetol. 2021 Apr 27;20(1):90. doi: 10.1186/s12933-021-01275-w.
4
ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition-implications for COVID-19.脂肪组织中 ACE2 的表达与心血管代谢危险因素和细胞类型组成有关——对 COVID-19 的影响。
Int J Obes (Lond). 2022 Aug;46(8):1478-1486. doi: 10.1038/s41366-022-01136-w. Epub 2022 May 20.
5
Angiotensin II receptors: Impact for COVID-19 severity.血管紧张素 II 受体:对 COVID-19 严重程度的影响。
Dermatol Ther. 2020 Nov;33(6):e13989. doi: 10.1111/dth.13989. Epub 2020 Jul 27.
6
ACE2: from protection of liver disease to propagation of COVID-19.ACE2:从保护肝脏疾病到传播 COVID-19。
Clin Sci (Lond). 2020 Dec 11;134(23):3137-3158. doi: 10.1042/CS20201268.
7
Resveratrol supplementation reduces ACE2 expression in human adipose tissue.白藜芦醇补充剂可降低人脂肪组织中 ACE2 的表达。
Adipocyte. 2021 Dec;10(1):408-411. doi: 10.1080/21623945.2021.1965315.
8
COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury.新型冠状病毒肺炎和肥胖:异位内脏和心外膜脂肪组织在心肌损伤中的作用。
Front Endocrinol (Lausanne). 2021 Aug 16;12:726967. doi: 10.3389/fendo.2021.726967. eCollection 2021.
9
Adipose tissue and blood leukocytes ACE2 DNA methylation in obesity and after weight loss.肥胖及减肥后脂肪组织和血白细胞 ACE2 DNA 甲基化。
Eur J Clin Invest. 2022 Feb;52(2):e13685. doi: 10.1111/eci.13685. Epub 2021 Oct 18.
10
Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2).致病分子:血管紧张素转化酶 2(ACE2)。
J Clin Pathol. 2021 May;74(5):285-290. doi: 10.1136/jclinpath-2020-206954. Epub 2020 Aug 5.

引用本文的文献

1
Perindopril and losartan affect ACE-2 and IL- 6 expression in obese rat model.培哚普利和氯沙坦对肥胖大鼠模型中ACE-2和IL-6表达的影响。
Narra J. 2024 Aug;4(2):e681. doi: 10.52225/narra.v4i2.681. Epub 2024 Jul 15.
2
Obesity-compromised immunity in post-COVID-19 condition: a critical control point of chronicity.肥胖损害新冠病毒感染后患者的免疫功能:慢性化的关键控制点。
Front Immunol. 2024 Aug 12;15:1433531. doi: 10.3389/fimmu.2024.1433531. eCollection 2024.
3
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic.

本文引用的文献

1
ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition-implications for COVID-19.脂肪组织中 ACE2 的表达与心血管代谢危险因素和细胞类型组成有关——对 COVID-19 的影响。
Int J Obes (Lond). 2022 Aug;46(8):1478-1486. doi: 10.1038/s41366-022-01136-w. Epub 2022 May 20.
2
Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers.可溶性血管紧张素转换酶2在新冠病毒病中短暂升高,并与特定的炎症和内皮标志物相关。
J Med Virol. 2021 Oct;93(10):5908-5916. doi: 10.1002/jmv.27144. Epub 2021 Jul 6.
3
新冠疫情期间和之后对 SARS-CoV-2 发病机制的新认识。
Front Immunol. 2024 Jun 7;15:1363572. doi: 10.3389/fimmu.2024.1363572. eCollection 2024.
4
COVID-19 and Comorbidities: What Has Been Unveiled by Metabolomics?2019冠状病毒病及其合并症:代谢组学揭示了什么?
Metabolites. 2024 Mar 30;14(4):195. doi: 10.3390/metabo14040195.
5
SARS-CoV-2 infection and its effects on the endocrine system.SARS-CoV-2 感染及其对内分泌系统的影响。
Best Pract Res Clin Endocrinol Metab. 2023 Jul;37(4):101761. doi: 10.1016/j.beem.2023.101761. Epub 2023 Mar 5.
6
The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury.肥胖与新冠后遗症:低氧血症、血栓性炎症和血管内皮损伤。
Front Cardiovasc Med. 2023 Feb 7;10:1062491. doi: 10.3389/fcvm.2023.1062491. eCollection 2023.
7
Risk Stratification Based on a Pattern of Immunometabolic Host Factors Is Superior to Body Mass Index-Based Prediction of COVID-19-Associated Respiratory Failure.基于免疫代谢宿主因素模式的风险分层优于基于体重指数的 COVID-19 相关呼吸衰竭预测。
Nutrients. 2022 Oct 13;14(20):4280. doi: 10.3390/nu14204280.
8
Obesity as a Risk Factor for Severe COVID-19 in Hospitalized Patients: Epidemiology and Potential Mechanisms.肥胖作为住院患者发生重症 COVID-19 的危险因素:流行病学及潜在机制
Healthcare (Basel). 2022 Sep 22;10(10):1838. doi: 10.3390/healthcare10101838.
9
SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages.SARS-CoV-2 感染通过感染脂肪细胞和巨噬细胞在人体脂肪组织中引发炎症反应。
Sci Transl Med. 2022 Dec 7;14(674):eabm9151. doi: 10.1126/scitranslmed.abm9151.
10
The Drosophila melanogaster ACE2 ortholog genes are differently expressed in obesity/diabetes and aging models: Implications for COVID-19 pathology.果蝇 ACE2 直系同源基因在肥胖/糖尿病和衰老模型中表达不同:对 COVID-19 病理的影响。
Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166551. doi: 10.1016/j.bbadis.2022.166551. Epub 2022 Sep 15.
Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients.
血浆 ACE2 可预测住院 COVID-19 患者的结局。
PLoS One. 2021 Jun 4;16(6):e0252799. doi: 10.1371/journal.pone.0252799. eCollection 2021.
4
Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study.在英格兰 690 万人中,体重指数与 COVID-19 严重程度的关联:一项前瞻性、基于社区的队列研究。
Lancet Diabetes Endocrinol. 2021 Jun;9(6):350-359. doi: 10.1016/S2213-8587(21)00089-9. Epub 2021 Apr 28.
5
Serum levels of ACE2 are higher in patients with obesity and diabetes.肥胖和糖尿病患者的血清血管紧张素转换酶2(ACE2)水平较高。
Obes Sci Pract. 2020 Dec 16;7(2):239-243. doi: 10.1002/osp4.472. eCollection 2021 Apr.
6
Immune dysregulation and system pathology in COVID-19.COVID-19 中的免疫失调与系统病理学。
Virulence. 2021 Dec;12(1):918-936. doi: 10.1080/21505594.2021.1898790.
7
Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients.危重症新型冠状病毒肺炎患者血液中血管紧张素转换酶2活性增加。
ERJ Open Res. 2021 Mar 15;7(1). doi: 10.1183/23120541.00848-2020. eCollection 2021 Jan.
8
Roux-en-Y Gastric Bypass Downregulates Angiotensin-Converting Enzyme 2 (ACE2) Gene Expression in Subcutaneous White Adipose Tissue: A Putative Protective Mechanism Against Severe COVID-19.胃旁路手术下调皮下白色脂肪组织中的血管紧张素转换酶 2 (ACE2) 基因表达:一种针对严重 COVID-19 的潜在保护机制。
Obes Surg. 2021 Jun;31(6):2831-2834. doi: 10.1007/s11695-021-05271-7. Epub 2021 Feb 21.
9
Developing new drugs that activate the protective arm of the renin-angiotensin system as a potential treatment for respiratory failure in COVID-19 patients.开发能激活肾素-血管紧张素系统保护机制的新药,有望成为治疗 COVID-19 患者呼吸衰竭的手段。
Drug Discov Today. 2021 May;26(5):1311-1318. doi: 10.1016/j.drudis.2021.02.010. Epub 2021 Feb 17.
10
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.糖尿病、肥胖症、新陈代谢与新型冠状病毒感染:开端的结束。
Cell Metab. 2021 Mar 2;33(3):479-498. doi: 10.1016/j.cmet.2021.01.016. Epub 2021 Jan 21.